High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia

BACKGROUND: Acute myeloid leukemia (AML) pertains to a hematologic malignancy with heterogeneous therapeutic responses. Improvements in risk stratification in AML patients are warranted. MicroRNAs have been associated with the pathogenesis of AML. METHODS: To examine the prognostic value of miR-25,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Cell Int
Main Authors: Niu, Mingshan, Feng, Yuan, Zhang, Ninghan, Shao, Tingting, Zhang, Huihui, Wang, Rong, Yao, Yao, Yao, Ruosi, Wu, Qingyun, Cao, Jiang, Liu, Xuejiao, Liu, Yubo, Xu, Kailin
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Primary Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6505210/
https://ncbi.nlm.nih.gov/pubmed/31080363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0843-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki